NDC11 70748013006
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 70748-0130-06 | 70748-0130 |
| 70748-0130-6 | 70748-0130 |
| 70748-130-06 | 70748-130 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Leflunomide | LEFLUNOMIDE | Lupin Pharmaceuticals, Inc. | 5d48fded-b43b-461a-8488-ca1da5c41a03 | 2025-10-29 | Boxed warning, Warnings, Adverse reactions | 70748-130-06 70748-130 70748013006 |
| Lefluniclo | LEFLUNOMIDE AND DICLOFENAC SODIUM GEL | V2 Pharma, LLC | 91d62919-c4bb-4dd0-af23-c5183bc53d00 | 2023-03-29 | Boxed warning, Warnings, Adverse reactions | 70748-130-06 70748013006 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.